Finally, we will investigate the presence of FOXM1 in the tumor microenvironment via a relatively novel quantitative technology—single-cell RNA-Seq—by leveraging studies where cancer and non-cancer cells are identified and sequenced in the same samples. This evidence concerns the gene FOXM1 and cancer.